Mizuho Maintains Outperform on Cardinal Health, Raises Price Target to $240

Benzinga Newsdesk www.benzinga.com Positive 92.8%

Neg 0% Neu 0% Pos 92.8%

Mizuho analyst Steven Valiquette maintains Cardinal Health (NYSE:CAH) with a Outperform and raises the price target from $235 to $240.